Novartis

Oggi

1. 17:22
   Novartis earnings analysis: questions answered and next catalystsinvesting.comen
2. 16:15
   Novartis takes $1.9bn writedown on key drug after blockbuster Avidity acquisitionFft.comen
3. 15:53
   Flop mit neuem Medikament kommt Novartis teuer zu stehennzz.chde
4. 13:48
   Novartis Hikes Income Forecast, But There Were Caveats Within Its Reportinvestors.comen
5. 12:46
   The Zacks Analyst Blog Highlights Intel, Novartis AG, Itau Unibanco and AMREPfinance.yahoo.comenItaú UnibancoIntel
6. 10:33
   Novartis batte le stime nel terzo trimestre e alza la guidance sull’utile operativo per il 2026wallstreetitalia.com
7. 07:36
   Novartis Raises Guidance Despite Trial Setbacks Hitting Profitwsj.comen
8. 07:25
   +++ Geschäftszahlen +++: Pharmakonzern Novartis schraubt Ergebnisprognose nach obenhandelsblatt.comde
9. 07:20
   Novartis Q3 Non-GAAP EPS of $2.46 beats by $0.22; FY core operating income outlook upgradedseekingalpha.comen
10. 06:47
    Gli EPS di Novartis ADR hanno battuto le aspettative per 0,18$, il fatturato appena sotto le previsioniit.investing.com
11. 06:47
    Novartis ADR earnings beat by $0.18, revenue fell short of estimatesinvesting.comen
12. 06:23
    Novartis alza le previsioni di utile annuale dopo la crescita del Q3it.investing.com
13. 06:23
    Novartis raises annual profit outlook after strong Q3 sales growthinvesting.comen

Ieri

1. 20:33
   Top Analyst Reports for Intel, Novartis & Itau Unibancofinance.yahoo.comenItaú UnibancoIntel
2. 17:57
   Novartis Q3 2026 Earnings Previewseekingalpha.comen
3. 09:02
   Novartis MS drug remibrutinib cuts relapses, no liver safety signal in trialsinvesting.comen
4. 09:02
   Il farmaco di Novartis per la SM riduce le ricadute senza tossicità epaticait.investing.com